Home > Newsletters > International Pharmaceutical Regulatory Monitor > Industry Groups in UK Update Insurance Guidance for Phase I Clinical Trials
International Pharmaceutical Regulatory Monitor
July 2012 | Vol. 40 No. 7
Industry Groups in UK Update Insurance Guidance for Phase I Clinical Trials
UK sponsors of Phase I clinical trials should take out adequate insurance policies in order to accelerate ethics committee review processes and assure volunteers they will be compensated if they suffer an injury or adverse event as a result of the study, according to a new industry best practice guideline.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.